These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 30257764

  • 1. Long-Term Effects of Intravenous Iloprost Therapy in Patients with Bone Marrow Oedema of the Knee Joint.
    Zippelius T, Matziolis G, Perka C, Putzier M, Strube P, Röhner E.
    Acta Chir Orthop Traumatol Cech; 2018; 85(1):17-21. PubMed ID: 30257764
    [Abstract] [Full Text] [Related]

  • 2. Long-term effects of intravenous iloprost therapy in patients with bone marrow oedema of the hip.
    Zippelius T, Perka C, Preininger B, Matziolis G, Strube P, Röhner E.
    Acta Orthop Belg; 2018 Jun; 84(2):172-178. PubMed ID: 30462600
    [Abstract] [Full Text] [Related]

  • 3. Effects of intravenous iloprost therapy in patients with bone marrow oedema of the foot and ankle.
    Röhner E, Zippelius T, Steindl D, Fussi J, Perka C.
    Eur J Orthop Surg Traumatol; 2014 Dec; 24(8):1609-16. PubMed ID: 24048706
    [Abstract] [Full Text] [Related]

  • 4. Treatment of Bone Marrow Edema of the Foot and Ankle With the Prostacyclin Analog Iloprost.
    Hörterer H, Baumbach SF, Gregersen J, Kriegelstein S, Gottschalk O, Szeimies U, Walther M.
    Foot Ankle Int; 2018 Oct; 39(10):1183-1191. PubMed ID: 29862844
    [Abstract] [Full Text] [Related]

  • 5. Short-term outcome of painful bone marrow oedema of the knee following oral treatment with iloprost or tramadol: results of an exploratory phase II study of 41 patients.
    Mayerhoefer ME, Kramer J, Breitenseher MJ, Norden C, Vakil-Adli A, Hofmann S, Meizer R, Siedentop H, Landsiedl F, Aigner N.
    Rheumatology (Oxford); 2007 Sep; 46(9):1460-5. PubMed ID: 17636179
    [Abstract] [Full Text] [Related]

  • 6. Rationale for prostaglandin I2 in bone marrow oedema--from theory to application.
    Jäger M, Tillmann FP, Thornhill TS, Mahmoudi M, Blondin D, Hetzel GR, Zilkens C, Krauspe R.
    Arthritis Res Ther; 2008 Sep; 10(5):R120. PubMed ID: 18834533
    [Abstract] [Full Text] [Related]

  • 7. MRI-controlled analysis of 104 patients with painful bone marrow edema in different joint localizations treated with the prostacyclin analogue iloprost.
    Meizer R, Radda C, Stolz G, Kotsaris S, Petje G, Krasny C, Wlk M, Mayerhöfer M, Landsiedl F, Aigner N.
    Wien Klin Wochenschr; 2005 Apr; 117(7-8):278-86. PubMed ID: 15926619
    [Abstract] [Full Text] [Related]

  • 8. Bone marrow edema syndrome in postpartal women: treatment with iloprost.
    Aigner N, Meizer R, Meraner D, Becker S, Meizer E, Landsiedl F.
    Orthop Clin North Am; 2009 Apr; 40(2):241-7. PubMed ID: 19358909
    [Abstract] [Full Text] [Related]

  • 9. The management of necrosis-associated and idiopathic bone-marrow oedema of the proximal femur by intravenous iloprost.
    Disch AC, Matziolis G, Perka C.
    J Bone Joint Surg Br; 2005 Apr; 87(4):560-4. PubMed ID: 15795211
    [Abstract] [Full Text] [Related]

  • 10. Bone marrow edema syndrome of the femoral head: treatment with the prostacyclin analogue iloprost vs. core decompression: an MRI-controlled study.
    Aigner N, Petje G, Schneider W, Meizer R, Wlk M, Kotsaris S, Knahr K, Landsiedl F.
    Wien Klin Wochenschr; 2005 Feb; 117(4):130-5. PubMed ID: 15847192
    [Abstract] [Full Text] [Related]

  • 11. Juvenile bone-marrow oedema of the acetabulum treated by iloprost.
    Aigner N, Petje G, Schneider W, Krasny C, Grill F, Landsiedl F.
    J Bone Joint Surg Br; 2002 Sep; 84(7):1050-2. PubMed ID: 12358371
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Extracorporeal shock wave therapy in the treatment of primary bone marrow edema syndrome of the knee: a prospective randomised controlled study.
    Gao F, Sun W, Li Z, Guo W, Wang W, Cheng L, Yue D, Zhang N, Savarin A.
    BMC Musculoskelet Disord; 2015 Dec 05; 16():379. PubMed ID: 26637992
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Efficiency of iloprost treatment for osseous malperfusion.
    Jäger M, Zilkens C, Bittersohl B, Matheney T, Kozina G, Blondin D, Krauspe R.
    Int Orthop; 2011 May 05; 35(5):761-5. PubMed ID: 20306261
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Factors influencing outcome of knee bone marrow oedema: a clinical study.
    Berkem L, Turkmen I, Unay K, Akcal MA, Aydemir N.
    Acta Orthop Belg; 2013 Oct 05; 79(5):572-7. PubMed ID: 24350521
    [Abstract] [Full Text] [Related]

  • 19. Treatment of bone marrow edema syndrome with intravenous ibandronate.
    Bartl C, Imhoff A, Bartl R.
    Arch Orthop Trauma Surg; 2012 Dec 05; 132(12):1781-8. PubMed ID: 23053191
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.